Abdulla Eman, Abdulla Zainab, Alalawi Warda, Fathalla Shaikha, Asad Farah
General Practice, Mansoura University, Mansoura, EGY.
General Practice, First Moscow State Medical University, Moscow, RUS.
Cureus. 2024 Apr 11;16(4):e58062. doi: 10.7759/cureus.58062. eCollection 2024 Apr.
Orbital hemangiomas are benign vascular tumors commonly affecting infants and young children, often manifesting with proptosis, eyelid swelling, or discoloration. Propranolol has emerged as the primary therapy due to its efficacy in promoting regression and minimizing complications. Here, we present a case of a previously healthy six-month-old male infant with progressive right eyelid swelling and discoloration. Magnetic resonance imaging confirmed a large orbital hemangioma. The patient was referred to an ophthalmology center where treatment with propranolol resulted in substantial improvement. Early recognition and initiation of propranolol therapy are crucial in managing orbital hemangiomas in pediatric patients. This case underscores the successful outcome achievable with pharmacologic intervention and emphasizes the importance of long-term follow-up for monitoring and optimizing patient outcomes.
眼眶血管瘤是一种常见于婴幼儿的良性血管肿瘤，常表现为眼球突出、眼睑肿胀或变色。普萘洛尔因其在促进肿瘤消退和减少并发症方面的疗效，已成为主要治疗方法。在此，我们报告一例既往健康的6个月大男婴，出现进行性右眼睑肿胀和变色。磁共振成像证实为巨大眼眶血管瘤。该患者被转诊至眼科中心，接受普萘洛尔治疗后有显著改善。早期识别并开始普萘洛尔治疗对于小儿眼眶血管瘤的管理至关重要。本病例强调了药物干预可取得成功结果，并强调了长期随访对于监测和优化患者预后的重要性。
